Combining Esketamine and Prolonged Exposure for PTSD: A Proof-of-Concept Clinical Trial
Phase: PHASE1, PHASE2 | Sponsor: The University of Texas Health Science Center at San Antonio | Compound: Ketamine
- Status
- recruiting
- Institution
- The University of Texas Health Science Center at San Antonio
- Start date
- 2025-06-09
- End date
- 2025-12-30
- Registry ID
- NCT06795659
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.